Andy Stergachis, PhD, MS, BPharm, is a Professor of Pharmacy and Global Health and Adjunct Professor of Health Metrics Sciences and Epidemiology and Director of the Global Medicines Program at the University of Washington, Seattle, WA USA.  He has developed and evaluated novel approaches for safety surveillance of essential medicines and vaccines in low- and middle-income countries.  His recent projects include pharmacovigilance system strengthening; active safety surveillance of TB preventive therapy for PLHIV; sentinel site readiness for maternal immunization active safety surveillance; and the global burden of antimicrobial resistance. 

He serves on the CEPI-funded Safety Platform for Emergency Vaccines (SPEAC) Project and the Background Rates of Adverse Events for Vaccine Evaluation in Africa (BRAVE) Project.  He is an elected member of the US National Academy of Medicine, Fellow of the American Association for the Advancement of Science, Fellow of the American Pharmacists Association, and of the International Society for Pharmacoepidemiology.  Previously, he assisted with the establishment of the University of Namibia School of Pharmacy and strengthening the Therapeutics Information and Pharmacovigilance Centre (TIPC) in Namibia.